News
Wales takes UK lead on needle-free anaphylaxis prevention
Wales has recommended ALK's EURneffy nasal spray as a needle-free option for emergency treatment of severe allergic reactions, including anaphylaxis.
News
Legend Biotech names ex-Novartis exec as CEO
Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.
News
FDA backs Curium's Bexlutry as 1st 'radioligand equivalent'
Curium's copycat version of Novartis GEP-NET therapy Lutathera, Bexlutry, is the first radioligand equivalent (RLE) to be approved by the FDA.
Sales & Marketing
The patient communication crisis pharma can no longer ignore
Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.
News
Chiesi fills permanent CEO role with Flagship's Khougazian
Chiesi has named Flagship's David Khougazian as its new permanent chief executive, following the departure of Giuseppe Accogli earlier this year.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
